• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • shRNA
      • shARC Platform
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us
  • Home
  • Investors
  • Shareholders Information

Shareholders Information

Shareholders Information

Equity Threshold (as of December 8, 2021)

EQUITY_2_12.8

Voting Threshold (as of December 8, 2021)

VOTING

Total Number of Shares And Voting Rights

Total amount of share capital (EUR) (as of May 25, 2022) 78,584,224.33
Total number of shares with single voting rights (as of May 25, 2022) 20,225,581
Total number of shares with double voting rights (as of May 25, 2022) 2,368,375
Total number of shares (as of May 25, 2022) 22,593,956
Total number of voting rights (as of May 25, 2022) 24,962,331
Total number of attributed warrants (as of May 25, 2022) 1,997,190
Total number of shares with voting rights that could be created following the exercise of the attributed warrants (as of May 25, 2022) 1,997,190
Total number of diluted shares (outstanding shares + warrants) (as of May 25, 2022) 24,591,146
Total number of diluted shares with voting rights (as of May 25, 2022) 26,959,521

Transparency Declarations

17 Dec 2021 Tolefi SA
13 Dec 2021 Fortress Investment Group LLC
19 May 2021 Victory Capital Management Inc.
05 May 2021 Tolefi SA
28 Sep 2018 Victory Capital Management Inc.
01 Jun 2018 Tolefi SA
17 Feb 2017 Tolefi SA
03 Aug 2016 Medisun International Ltd and National Fund Ltd
29 Jun 2015 PMV-TINA
29 Jun 2015 SRIW SA
05 Mar 2015 Tolefi SA
20 Aug 2014 Tolefi SA
12 Jul 2013 Tolefi SA, PMV NV, SRIW SA/ Sofipole SA, Mayo Foundation

Investor Contact Information:

Investors@celyad.com

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use